Circulating Autoantibodies to LGALS3BP: A Novel Biomarker for Cancer

Table 3

Serum levels of LGALS3BP.

	N	𝜇g/mL (Mean ± SD)
Controls	54	6.36±1.16
Cancers	71	13.19±2.37
GI	15	16.68±0.95
NSCLC	13	12.17±0.75
BC	12	14.07±1.08
NET	10	10.28±1.25
UG	10	13.13±1.2
M	7	11.13±0.66
Others	4	11.73±0.93

GI: gastrointestinal cancer; NSCLC: non-small-cell lung cancer; BC: breast cancer; NET: neuroendocrine tumors; UG: urogenital tract cancer; M: melanoma.